Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes-Reference-Cited by-同舟云学术

Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes

Published:2002-04 Issue:4 Volume:20 Page:707-714
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:Journal of Hypertension

Author:

Tikkanen Ilkka,Tikkanen Tuula,Cao Zemin,Allen Terri J.,Davis Belinda J.,Lassila Markus,Casley David,Johnston Colin I.,Burrell Louise M.,Cooper Mark E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference38 articles.

1. New Hormonal Blockade Strategies in Cardiovascular Disease

2. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.

3. Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase in Rats with Hypertension

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Landscape of Therapeutics for the Management of Hypertension - A Review;Current Drug Delivery;2024-06

2. Angiotensin Converting Enzyme-2 (ACE-2): A Target for Novel Drug Development;Advances in Biochemistry in Health and Disease;2024

3. The Natriuretic Peptides for Hypertension Treatment;High Blood Pressure & Cardiovascular Prevention;2021-11-02

4. Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db / db diabetic mice;Physiological Reports;2020-02

5. New Molecules for Treating Resistant Hypertension: a Clinical Perspective;Current Hypertension Reports;2019-09-10